[HTML][HTML] A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay, R D'Rozario… - Nature …, 2022 - nature.com
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - ui.adsabs.harvard.edu
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Y Ray, SR Paul, P Bandopadhyay, R D'Rozario… - Nat …, 2022 - pesquisa.bvsalud.org
ABSTRACT A single center open label phase 2 randomised control trial (Clinical Trial
Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological …
Registry of India No. CTRI/2020/05/025209) was done to assess clinical and immunological …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - search.ebscohost.com
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
[HTML][HTML] A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - ncbi.nlm.nih.gov
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - ideas.repec.org
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - econpapers.repec.org
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
[PDF][PDF] A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19
Y Ray - scienceopen.com
Supplemental figure 1. Additional characterization of convalescent donors.(A) Day since
being tested positive for SARS-CoV2 on RT-PCR for all convalescent donors.(B) Correlation …
being tested positive for SARS-CoV2 on RT-PCR for all convalescent donors.(B) Correlation …
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
Y Ray, SR Paul, P Bandopadhyay… - Nature …, 2022 - europepmc.org
A single center open label phase 2 randomised control trial (Clinical Trial Registry of India
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …
No. CTRI/2020/05/025209) was done to assess clinical and immunological benefits of …